CHICAGO--(BUSINESS WIRE)--The board of Therapeutic Proteins International (TPI) today announced the appointment of Peter F. Moesta, Ph.D. as its new chief executive officer, effective November 2, 2015. Dr. Moesta will also serve on the company’s board.
Dr. Moesta has more than 30 years of experience in the biopharmaceutical industry, most recently as the senior vice president for biologics development and operations at Bristol-Myers Squibb.
Help employers find you! Check out all the jobs and post your resume.
